Skip to main content

Table 3 Change in the impact of French Alzheimer disease research between the periods 2004–2008 and 2009–2013, as assessed by research output and representation in the top 1 % globally cited articles compared with French scientific output in stroke, Parkinson disease, HIV, and diabetes

From: The Third French Alzheimer Plan: analysis of the influence of a national public health initiative on scientific research productivity and impact

  Research output (% France’s share of output) Output relative increase (fold change) France’s share of top 1 % globally cited articles Top 1 % relative increase (fold change)
  2004–2008 2009–2013 2004–2008 2009–2013
Alzheimer disease 1, 082 (0.4 %) 1, 836 (0.6 %) 3.9 18 (0.7 %) 44 (1.1 %) 2.3
Diabetes 2, 890 (1.1 %) 3, 725 (1.2 %) 1.6 75 (3.0 %) 130 (3.2 %) 1.2
HIV 3, 092 (1.1 %) 3, 297 (1.0 %) 0.4 43 (1.7 %) 58 (1.4 %) 0.6
Parkinson disease 997 (0.4 %) 1, 281 (0.4 %) 1.6 17 (0.7 %) 21 (0.5 %) 0.4
Stroke 1, 495 (0.5 %) 2, 264 (0.7 %) 2.9 46 (1.8 %) 98 (2.0 %) 1.8
Overall 270, 314 318, 946 1 2, 496 4, 041 1